Skip to Main Content

Paper Details

BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers.
Pediatr Blood Cancer
7
2021
Author NameAffiliation
Payal JainCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Payal JainCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Lea F SurreyChildren's Hospital of Philadelphia
Joshua StrakaCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Pierre RussoChildren's Hospital of Philadelphia
Richard B WomerChildren's Hospital of Philadelphia (CHOP)
Marilyn M LiChildren's Hospital of Philadelphia
Marilyn M LiChildren's Hospital of Philadelphia
Phillip B StormCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Phillip B StormThe Children's Hospital of Philadelphia
Phillip B StormUniversity of Pennsylvania
Phillip B StormCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Phillip B StormUniversity of Pennsylvania
Phillip B StormThe Children's Hospital of Philadelphia
Angela J WaandersFeinberg School of Medicine Northwestern University
Angela J WaandersFeinberg School of Medicine Northwestern University
Michael D HogartyChildren's Hospital of Philadelphia (CHOP)
Adam C ResnickCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Adam C ResnickCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia
Jennifer PicarsicUniversity of Pittsburgh School of Medicine
Jennifer PicarsicCincinnati Children's Hospital Medical Center
  • 1 - 21

Datasets